<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Erythroderma in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Erythroderma in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Erythroderma in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1045878386"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Erythroderma is a generalized and persistent erythema of the skin involving at least 90 percent of the body surface [<a href="#rid1">1</a>]. Although relatively uncommon in infants, erythroderma may be the presenting feature of a wide range of acquired and inherited diseases, including infections, inflammatory skin diseases, ichthyoses, and congenital immunodeficiencies.</p><p>This topic will review the causes of erythroderma in children and the approach to the diagnosis and management. Erythroderma in adults is discussed separately. (See  <a class="medical medical_review" href="/d/html/13659.html" rel="external">"Erythroderma in adults"</a>.)</p><p class="headingAnchor" id="H1045878393"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Neonatal and infantile erythrodermas are associated with a wide range of underlying cutaneous and systemic disorders, including [<a href="#rid1">1-3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Infectious diseases (eg, staphylococcal scalded skin syndrome, congenital cutaneous candidiasis, syphilis)</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory diseases (eg, atopic dermatitis, seborrheic dermatitis, psoriasis)</p><p class="bulletIndent1"><span class="glyph">●</span>Inherited ichthyoses</p><p class="bulletIndent1"><span class="glyph">●</span>Primary immunodeficiencies</p><p class="bulletIndent1"><span class="glyph">●</span>Inborn errors of metabolism</p><p class="bulletIndent1"><span class="glyph">●</span>Drug hypersensitivity reactions</p><p></p><p>Determining the underlying cause of erythroderma is rarely possible without laboratory, histologic, microbiologic, or molecular genetic testing. The choice of the appropriate laboratory studies is based upon history and clinical presentation.</p><p class="headingAnchor" id="H1045878400"><span class="h2">Infectious diseases</span></p><p class="headingAnchor" id="H1045878407"><span class="h3">Staphylococcal scalded skin syndrome</span><span class="headingEndMark"> — </span>In neonates and infants, diffuse erythema with superficial desquamation and/or bullae not involving the mucous membranes suggests staphylococcal scalded skin syndrome (SSSS) (<a class="graphic graphic_picture graphicRef72261 graphicRef121041" href="/d/graphic/72261.html" rel="external">picture 1A-B</a>) [<a href="#rid4">4</a>]. SSSS is a toxin-mediated illness caused by infection with phage group II <em>Staphylococcus aureus, </em>which produces the exfoliative toxins A and B [<a href="#rid5">5</a>]. These toxins bind to the desmosomal adhesion protein desmoglein-1 and induce cleavage of the epidermis at the level of the granular layer, resulting in acantholysis and blister formation (<a class="graphic graphic_picture graphicRef80198" href="/d/graphic/80198.html" rel="external">picture 2</a>).</p><p>The diagnosis is usually clinical, but bacterial cultures should be obtained from the nasopharynx, axillary skin, urine, and blood. SSSS is a life-threatening condition that often evolves rapidly. Prompt diagnosis and institution of therapy is crucial to avoid poor clinical outcomes. (See  <a class="medical medical_review" href="/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Staphylococcal scalded skin syndrome'</a> and  <a class="medical medical_review" href="/d/html/114922.html" rel="external">"Staphylococcal scalded skin syndrome"</a>.)</p><p class="headingAnchor" id="H60263451"><span class="h3">Staphylococcal toxic shock syndrome</span><span class="headingEndMark"> — </span>Staphylococcal toxic shock syndrome may infrequently cause erythroderma in neonates and infants [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/3161.html" rel="external">"Staphylococcal toxic shock syndrome"</a>.)</p><p class="headingAnchor" id="H261817547"><span class="h4">Neonatal toxic shock syndrome-like exanthematous disease</span><span class="headingEndMark"> — </span>Neonatal toxic shock syndrome-like exanthematous disease (NTED) is a newly described disease that has been reported in neonates in Japan and France who are colonized with methicillin-resistant <em>S. aureus</em>, producing the toxic shock syndrome toxin 1 [<a href="#rid7">7-9</a>]. NTED typically presents in the first few days of life with fever and generalized macular erythema that tends to coalesce. Thrombocytopenia (&lt;150,000/microL) and low positive level of C-reactive protein (1 to 5 mg/dL) are also present.</p><p>The disease appears to be less severe than toxic shock syndrome and usually regresses spontaneously in neonatal patients without active treatment.</p><p class="headingAnchor" id="H1045878414"><span class="h3">Congenital cutaneous candidiasis</span><span class="headingEndMark"> — </span>Congenital cutaneous candidiasis presents at birth or in the first few days of life with small, diffuse, erythematous macules and pustules, often involving the palms and soles (<a class="graphic graphic_picture graphicRef118658 graphicRef94975" href="/d/graphic/118658.html" rel="external">picture 3A-B</a>) [<a href="#rid10">10</a>]. Widespread crusting and erosions and a generalized erythema may also be present. The infection can be acquired in utero via ascending infection from maternal vulvovaginal area or at birth.</p><p>Infants with this presentation do not appear ill and usually do not have systemic disease. However, mucocutaneous <em>Candida</em> infection can be seen in neonates with primary immunodeficiencies [<a href="#rid11">11</a>]. Premature neonates, usually between one to three weeks of age, can present with diffuse scaling, crusting, and erosions as a manifestation of neonatal candidiasis. Premature infants are at increased risk for developing candidemia and multiple organ infection.</p><p>Diagnosis is confirmed by appropriate laboratory investigations, such as potassium hydroxide (KOH) examination, which reveals the typical pseudohyphae and clusters of oval or round yeast cells (<a class="graphic graphic_picture graphicRef79879" href="/d/graphic/79879.html" rel="external">picture 4</a>), histopathology (when indicated), and culture. In every case, evaluation for the possibility of systemic infection must be kept in mind and should be guided by clinical considerations. (See  <a class="medical medical_review" href="/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates"</a>.)</p><p class="headingAnchor" id="H1045878421"><span class="h3">Syphilis</span><span class="headingEndMark"> — </span>Early congenital syphilis may present with widespread erythema and superficial scaling in the first six to eight weeks of life (<a class="graphic graphic_picture graphicRef95634" href="/d/graphic/95634.html" rel="external">picture 5</a>). Palm and sole involvement with bullae and/or localized desquamation associated with more widespread desquamation should alert the clinician to the possibility of this infection [<a href="#rid12">12-14</a>]. Additional clinical findings include fever, hepatomegaly, splenomegaly, and generalized lymphadenopathy. Condylomata lata can also be seen in these children (<a class="graphic graphic_picture graphicRef95629" href="/d/graphic/95629.html" rel="external">picture 6</a>).</p><p>Infants with suspected congenital syphilis should be evaluated with a quantitative nontreponemal test (rapid plasma reagin [RPR] or Venereal Disease Research Laboratory [VDRL]) performed on infant serum; if reactive, the infant should be examined thoroughly for evidence of congenital syphilis [<a href="#rid15">15</a>]. Darkfield examination or direct fluorescent antibody (DFA) staining of skin lesions and/or mucous membrane samples can demonstrate thin, corkscrew-shaped organisms with rigid, tightly wound spirals (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 7</a>). (See  <a class="medical medical_review" href="/d/html/14428.html" rel="external">"Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1045878428"><span class="h3">Herpes simplex</span><span class="headingEndMark"> — </span>Herpes simplex virus (HSV) infection in neonates and infants primarily results from intrapartum exposure to maternal cervical or vaginal lesions. Lesions are not usually present at birth but develop in the first few weeks of life. Infants typically present with discrete areas of pustules and/or vesicles (<a class="graphic graphic_picture graphicRef75059 graphicRef78598" href="/d/graphic/75059.html" rel="external">picture 8A-B</a>).</p><p>In rare cases, the infection can be acquired in utero. Newborns may present with more diffuse erythema with scales and erosions (<a class="graphic graphic_picture graphicRef55645" href="/d/graphic/55645.html" rel="external">picture 9</a>) [<a href="#rid16">16</a>]. Intrauterine HSV infection may be associated with involvement of the central nervous system, eyes, and viscera, including adrenal glands, liver, and lungs.</p><p>Comprehensive laboratory evaluation should be performed in infants with suspected HSV infection, including culture and histologic examination of affected tissues, DFA of swabs/scrapings of skin or mucous membrane lesions, and HSV DNA polymerase chain reaction (PCR) of the blood and cerebrospinal fluid. (See  <a class="medical medical_review" href="/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H1337109779"><span class="h3">Human T lymphotropic virus type 1</span><span class="headingEndMark"> — </span>Infective dermatitis is a severe, chronic, relapsing dermatitis associated with human T lymphotropic virus (HTLV) type 1 [<a href="#rid17">17</a>]. First described in Jamaican children, infective dermatitis has been recognized in several endemic areas, including Brazil, Japan, and the Caribbean. One of the most common transmission modes is mother-to-child vertical transmission, primarily through breast feeding.</p><p>Infective dermatitis is characterized by a severe erythematous and exudative dermatitis with scaling and crusting primarily affecting the scalp, forehead, eyelids, paranasal area, neck, retroauricular areas, external ear, axillae, and groin. The onset is usually in early childhood, and the condition tends to improve with age. Rarely, infective dermatitis may present as exfoliative erythroderma in infants [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/8317.html" rel="external">"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment", section on 'Infective dermatitis'</a>.)</p><p class="headingAnchor" id="H1271281640"><span class="h3">Scabies</span><span class="headingEndMark"> — </span>In newborns and infants, a very itchy eruption with erythroderma and hyperkeratotic areas may be the presentation of crusted (or Norwegian) scabies, which means a heavy infestation by mites probably due to decreased immune defenses in newborns and infants. (See  <a class="medical medical_review" href="/d/html/4038.html" rel="external">"Scabies: Epidemiology, clinical features, and diagnosis", section on 'Crusted scabies'</a>.)</p><p class="headingAnchor" id="H1045878435"><span class="h2">Inflammatory diseases</span></p><p class="headingAnchor" id="H1045878442"><span class="h3">Atopic dermatitis</span><span class="headingEndMark"> — </span>Atopic dermatitis, although a common condition in the general population, is unusual in neonates. However, atopic dermatitis can be seen during infancy and may present with diffuse erythroderma (<a class="graphic graphic_picture graphicRef68746" href="/d/graphic/68746.html" rel="external">picture 10</a>).</p><p>Clues to the diagnosis of atopic dermatitis include the presence of pruritus, scratching (in infants old enough to scratch), and involvement of skin sites usually affected by the infantile form of atopic dermatitis such as the face, torso, and extremities. Typically, the diaper area is spared due to moisture and occlusion. A family history of atopy is usually present.</p><p>Erythrodermic atopic dermatitis should be differentiated from other eczematous and inflammatory skin diseases, including seborrheic dermatitis, psoriasis, immunodeficiency syndromes, and Netherton syndrome. (See  <a class="medical medical_review" href="/d/html/1729.html" rel="external">"Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1045878449"><span class="h3">Psoriasis</span><span class="headingEndMark"> — </span>One percent or less of all cases of psoriasis occur in infants [<a href="#rid19">19,20</a>]. Infantile psoriasis commonly presents with involvement of the diaper area and often other areas, such as the scalp, axillae, and extremities. The skin of the diaper area, including the folds, appears glossy and erythematous and may show superficial erosions (<a class="graphic graphic_picture graphicRef95639" href="/d/graphic/95639.html" rel="external">picture 11</a>) [<a href="#rid21">21</a>]. Pustular psoriasis can also be seen during infancy. In some cases, especially if associated with bone disease, it can be an indicator of the rare genetic autoinflammatory syndromes DIRA (deficiency of interleukin-1 receptor antagonist) and DITRA (deficiency of the interleukin-36 receptor antagonist) [<a href="#rid22">22,23</a>]. (See  <a class="medical medical_review" href="/d/html/110152.html" rel="external">"Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis", section on 'Pustular and erythrodermic psoriasis'</a> and  <a class="medical medical_review" href="/d/html/5597.html" rel="external">"The autoinflammatory diseases: An overview"</a>.)</p><p>Congenital erythrodermic psoriasis is exceedingly rare [<a href="#rid24">24,25</a>]. Erythroderma may be the presentation of infantile psoriasis or may occur later in childhood. Patients present with generalized erythema and thickening of the skin. Localized or diffuse sterile pustules may be seen on the background erythema.</p><p>The clinical diagnosis is difficult. A skin biopsy may show typical features of psoriasis, including psoriasiform hyperplasia, laminated parakeratosis, spongiform pustula, and mild dermal lymphocytic infiltrate [<a href="#rid26">26</a>]. (See <a class="local">'Skin biopsy'</a> below.)</p><p>However, during erythrodermic flares, histology often shows nonspecific inflammatory features. In such cases, and especially in the absence of family history of psoriasis, the diagnosis is made later in the course of the disease, when the classic presentation with sharply demarcated, deep red plaques with overlying white or "silvery" scale becomes apparent (<a class="graphic graphic_picture graphicRef74892" href="/d/graphic/74892.html" rel="external">picture 12</a>). (See  <a class="medical medical_review" href="/d/html/5664.html" rel="external">"Psoriasis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1045878456"><span class="h3">Seborrheic dermatitis</span><span class="headingEndMark"> — </span>Commonly seen during the neonatal and infantile ages, seborrheic dermatitis presents with erythematous patches and plaques with "greasy" scales that more prominent over typical locations, such as the scalp, face, axillae, and groin (<a class="graphic graphic_picture graphicRef73813 graphicRef52803" href="/d/graphic/73813.html" rel="external">picture 13A-B</a>). Occasionally, seborrheic dermatitis may present as erythroderma; in most cases, this presentation occurs in association with immunodeficiency and failure to thrive.</p><p>The distinction between erythrodermic seborrheic dermatitis and psoriasis or atopic dermatitis may be difficult, and the two conditions may overlap in some patients [<a href="#rid5">5</a>]. The spontaneous improvement of seborrheic dermatitis over weeks to months helps to differentiate it from atopic dermatitis or psoriasis, which usually have a chronic, prolonged course. (See  <a class="medical medical_review" href="/d/html/16261.html" rel="external">"Cradle cap and seborrheic dermatitis in infants"</a>.)</p><p class="headingAnchor" id="H1045878463"><span class="h3">Pityriasis rubra pilaris</span><span class="headingEndMark"> — </span>Pityriasis rubra pilaris is exceedingly rare during the neonatal or infantile ages. It presents with scaling follicular papules with or without palmoplantar keratoderma (<a class="graphic graphic_picture graphicRef95658 graphicRef95659" href="/d/graphic/95658.html" rel="external">picture 14A-B</a>) [<a href="#rid5">5</a>]. A family history of this condition may be found.</p><p>The diagnosis is based upon the combination of characteristic clinical and histopathologic features. Histology shows orthokeratosis with spotty parakeratosis, epidermal acanthosis, and a mild dermal lymphohistiocytic infiltrate but also may be nondiagnostic. (See  <a class="medical medical_review" href="/d/html/15283.html" rel="external">"Pityriasis rubra pilaris: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1045878470"><span class="h3">Diffuse cutaneous mastocytosis</span><span class="headingEndMark"> — </span>In the neonate, the clinical finding of diffusely infiltrated (thickened) skin with erythema and episodes of vesiculation or blistering should raise the suspicion of diffuse cutaneous mastocytosis (<a class="graphic graphic_picture graphicRef95683" href="/d/graphic/95683.html" rel="external">picture 15</a>) [<a href="#rid27">27-29</a>]. This condition is a rare variant of cutaneous mastocytosis that typically presents at birth or in early infancy.</p><p>A skin biopsy is necessary to confirm the diagnosis. Histology shows a dense, band-like infiltrate of mast cells with a granulated cytoplasm in the upper dermis. Granules are not visible with routine stains but may be seen with a Giemsa stain.</p><p>Symptoms include flushing, itching, vesiculation, diarrhea, gastrointestinal bleeding, abdominal pain, vomiting, and hypotension. The clinical course can be severe and even life-threatening, due to the potential for circulatory compromise and anaphylactoid reactions from sudden mast cell degranulation.</p><p>Systemic involvement may occur but is rare. Unexplained peripheral blood abnormalities, hepatomegaly, splenomegaly, or lymphadenopathy indicate systemic involvement [<a href="#rid30">30</a>].</p><p>The utility of serum tryptase levels for the diagnosis of diffuse cutaneous mastocytosis is not entirely clear but can help point toward the need for evaluation of other sites of involvement, such as bone, bone marrow, or gastrointestinal tract [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/d/html/103161.html" rel="external">"Mastocytosis (cutaneous and systemic) in children: Epidemiology, clinical manifestations, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H57626955"><span class="h2">Inherited ichthyoses</span><span class="headingEndMark"> — </span>Neonatal erythroderma may be the clinical presentation of several nonsyndromic and syndromic congenital ichthyoses (<a class="graphic graphic_table graphicRef90504 graphicRef90509" href="/d/graphic/90504.html" rel="external">table 1A-B</a>). (See  <a class="medical medical_review" href="/d/html/112583.html" rel="external">"Autosomal recessive congenital ichthyoses"</a>.)</p><p class="headingAnchor" id="H55269976"><span class="h3">Nonsyndromic</span><span class="headingEndMark"> — </span>The nonsyndromic<strong> </strong>autosomal recessive congenital ichthyoses (ARCI), which include lamellar ichthyosis, congenital ichthyosiform erythroderma, and Harlequin ichthyosis, present at birth as erythroderma with or without a collodion membrane (<a class="graphic graphic_picture graphicRef62827" href="/d/graphic/62827.html" rel="external">picture 16</a> and <a class="graphic graphic_table graphicRef128361" href="/d/graphic/128361.html" rel="external">table 2</a>) [<a href="#rid33">33</a>]. When the membrane is shed, the severity of long-term skin involvement is unpredictable based upon the neonatal presentation. The majority of infants with ARCI develop a diffuse erythema with fine white scale. The other phenotype seen after the shedding of the collodion membrane has less erythema and a thicker lamellar-type of scale.</p><p>At birth, epidermolytic ichthyosis (EI) often presents with erythroderma and features similar to epidermolysis bullosa. Neonates have areas of erosive epidermal loss mixed with hyperkeratotic skin without involvement of the mucous membrane (<a class="graphic graphic_picture graphicRef90570" href="/d/graphic/90570.html" rel="external">picture 17</a>). Over time, the blistering subsides, erythroderma becomes more obvious, and hyperkeratosis may become prominent, particularly at the flexures (<a class="graphic graphic_picture graphicRef90578 graphicRef90580" href="/d/graphic/90578.html" rel="external">picture 18A-B</a>). The diagnosis is based upon characteristic findings on histopathologic examination of a skin biopsy, which include epidermal hyperplasia with compact hyperorthokeratosis and ostia plugs, normal or thickened granulosus layer, and little or absent lymphocytic infiltrate [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H55269989"><span class="h3">Syndromic</span><span class="headingEndMark"> — </span>Erythroderma can be the presenting symptom of several syndromic forms of ichthyosis (<a class="graphic graphic_table graphicRef90509" href="/d/graphic/90509.html" rel="external">table 1B</a>), including Netherton syndrome, Sjögren-Larsson syndrome (SLS), and Conradi-Hünermann-Happle syndrome. (See  <a class="medical medical_review" href="/d/html/112583.html" rel="external">"Autosomal recessive congenital ichthyoses"</a> and  <a class="medical medical_review" href="/d/html/15474.html" rel="external">"Netherton syndrome"</a>.)</p><p>SLS is caused by mutations in the <em>ALDH3A2</em> gene, which codes for fatty acid aldehyde dehydrogenase and is inherited in an autosomal recessive fashion [<a href="#rid34">34</a>]. Affected children can have a phenotype similar to ARCI but ultimately develop spasticity and intellectual disability. The characteristic glistening dots on the retina of these patients are not uniformly seen. (See  <a class="medical medical_review" href="/d/html/1699.html" rel="external">"Sjögren-Larsson syndrome"</a>.)</p><p>Conradi-Hünermann syndrome (chondrodysplasia punctata type 2) is an X-linked dominant disorder caused by mutations in the <em>EBP</em> gene (emopamil-binding protein) encoding an 8-7 sterol isomerase involved in cholesterol metabolism. Affected female neonates present at birth with a diffuse or linear scaling erythema. Ultimately, ichthyosis with hyper- or hypopigmentation develops along the lines of Blaschko. Additional findings include follicular atrophoderma and scarring alopecia. Extracutaneous signs include dwarfism, cataracts, and psychomotor retardation. Stippled epiphyses should be sought by plain radiographs at birth in suspected cases. (See  <a class="medical medical_review" href="/d/html/108252.html" rel="external">"Skeletal dysplasias: Specific disorders", section on 'Chondrodysplasia punctata'</a>.)</p><p>Erythroderma can also be seen in cases of keratitis-ichthyosis-deafness (KID) syndrome due to mutations in connexin 26 gene (<em>GJB2</em>). Newborns with neutral lipid storage disease (Chanarin-Dorfman syndrome) may present with either erythroderma or a collodion membrane. Infants with ichthyosis prematurity syndrome may appear identical to those with KID syndrome at birth but do not have associated keratitis and deafness. (See  <a class="medical medical_review" href="/d/html/15465.html" rel="external">"Overview and classification of the inherited ichthyoses", section on 'KID syndrome'</a> and  <a class="medical medical_review" href="/d/html/6197.html" rel="external">"Metabolic myopathies caused by disorders of lipid and purine metabolism", section on 'Neutral lipid storage diseases'</a>.)</p><p class="headingAnchor" id="H57627012"><span class="h3">Netherton syndrome</span><span class="headingEndMark"> — </span>Netherton syndrome is an autosomal recessive disorder caused by mutations in the <em>SPINK5</em> gene, which encodes a kinase known as LEKTI [<a href="#rid3">3,35</a>]. Netherton syndrome should be considered in any infant with diffuse inflammatory skin disease and failure to thrive (<a class="graphic graphic_picture graphicRef87482" href="/d/graphic/87482.html" rel="external">picture 19</a>). Most, but not all, patients will also show abnormally brittle hair (<a class="graphic graphic_picture graphicRef87481" href="/d/graphic/87481.html" rel="external">picture 20</a>).</p><p>The examination of hairs for the typical "bamboo-hair" deformity known as trichorrhexis invaginata (<a class="graphic graphic_picture graphicRef87483" href="/d/graphic/87483.html" rel="external">picture 21</a>) is helpful for the clinical diagnosis. Immunostaining of a skin biopsy with a specific monoclonal antibody against the serine protease inhibitor LEKTI can be used to establish the diagnosis [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/15474.html" rel="external">"Netherton syndrome"</a>.)</p><p class="headingAnchor" id="H1045878563"><span class="h2">Immunodeficiency</span><span class="headingEndMark"> — </span>Newborns and infants with persistent and diffuse dermatitis or erythroderma and failure to thrive must bring to mind the possibility of primary immunodeficiencies [<a href="#rid36">36-38</a>]. In the United States, many states now include screening for T cell immunodeficiencies in their newborn screening programs. T cell receptor excision circles (TRECs) are the basis of these tests and measure new and naïve T cells [<a href="#rid39">39,40</a>]. (See  <a class="medical medical_review" href="/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview"</a> and  <a class="medical medical_review" href="/d/html/16363.html" rel="external">"Newborn screening for inborn errors of immunity"</a>.)</p><p class="headingAnchor" id="H59261496"><span class="h3">Severe combined immunodeficiency</span><span class="headingEndMark"> — </span>Severe combined immunodeficiency (SCID) syndromes are a heterogeneous group of disorders arising from a disturbance in the development and function of both T and B cells (cellular and humoral immunity) due to mutation in multiple genes, including interleukin receptor common gamma chain, recombinase activating gene (<em>RAG</em>) 1 or 2, adenosine deaminase, and Janus kinase 3. (See  <a class="medical medical_review" href="/d/html/3912.html" rel="external">"Severe combined immunodeficiency (SCID): Specific defects"</a>.)</p><p>Omenn syndrome is a form of SCID, due to hypomorphic mutations in <em>RAG1</em> and <em>RAG2</em>, characterized by a T-negative, B-negative, natural killer (NK)-positive phenotype. Newborns with Omenn syndrome present with erythroderma, lymphadenopathy, hepatosplenomegaly, profound eosinophilia, chronic persistent diarrhea, and failure to thrive. Some infants born with SCID will present with graft-versus-host disease due to maternal engraftment (transplacental passage of alloreactive maternal T cells). (See <a class="local">'Graft-versus-host disease'</a> below.)</p><p>In suspected cases, complete evaluation of the immune function should be done, including the measurement of immunoglobulin levels, absolute numbers and percentages of lymphocyte subsets (T, B, and natural killer), and assessment of T cell function. (See  <a class="medical medical_review" href="/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H1045878570"><span class="h3">Hyperimmunoglobulin E syndrome</span><span class="headingEndMark"> — </span>Hyperimmunoglobulin E syndrome (HIES) is a rare primary immunodeficiency characterized by elevated serum immunoglobulin E (IgE), skin eruption, and recurrent bacterial infections of the skin and lung [<a href="#rid41">41</a>]. There are two forms of HIES, caused by distinct genetic mutations, which are inherited in an autosomal dominant or recessive fashion. Both forms of the disease show classic features of eczema that is often diffuse or erythrodermic (<a class="graphic graphic_picture graphicRef61049" href="/d/graphic/61049.html" rel="external">picture 22</a>), skin abscesses, respiratory infection, marked elevation in serum IgE, mucocutaneous candidiasis, and eosinophilia [<a href="#rid42">42</a>].</p><p>Autosomal dominant HIES (Job syndrome) is the most frequent form. It is caused by mutations in the signal transducer and activator of transcription 3 gene (<em>STAT3</em>). These patients have predominantly bacterial infections of the skin, but sinopulmonary and skeletal infections are also common. Additional clinical features include hyperextensible joints, skeletal abnormalities, osteoporosis, and coarse facies. (See  <a class="medical medical_review" href="/d/html/3960.html" rel="external">"Autosomal dominant hyperimmunoglobulin E syndrome"</a>.)</p><p>Dedicator of cytokinesis 8 (DOCK8) deficiency, caused by loss-of-function mutations in the <em>DOCK8</em> gene, was previously classified as the autosomal recessive form of HIES, but many patients do not have elevated serum IgE [<a href="#rid43">43,44</a>]. It is suspected in patients with eczematous skin disease accompanied by severe cutaneous viral infections, such as herpes simplex, molluscum contagiosum, or varicella zoster [<a href="#rid42">42,45</a>]. Some patients may develop aggressive squamous cell carcinoma and cutaneous T cell lymphoma [<a href="#rid42">42,45</a>]. (See  <a class="medical medical_review" href="/d/html/141326.html" rel="external">"Combined immunodeficiencies: Specific defects", section on 'DOCK8 deficiency'</a>.)</p><p class="headingAnchor" id="H1045878577"><span class="h3">Wiskott-Aldrich syndrome</span><span class="headingEndMark"> — </span>Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive disorder characterized by thrombocytopenia, pyogenic infections, and a diffuse eczematous dermatitis [<a href="#rid36">36</a>]. It is caused by mutations in the gene encoding the Wiskott-Aldrich protein (WASp), which is involved in actin cytoskeleton remodeling and is widely expressed in the hematopoietic cell lines.</p><p>Affected male infants present with extensive eczema and thrombocytopenia, which can result in bleeding and a hemorrhagic appearance of the dermatitis (<a class="graphic graphic_picture graphicRef95686" href="/d/graphic/95686.html" rel="external">picture 23</a>). Patients may also have epistaxis, gastrointestinal, or central nervous system hemorrhage. Bacterial, viral, and opportunistic infections due to <em>Pneumocystis</em> can be seen [<a href="#rid37">37</a>]. Lymphoproliferative disorders and autoimmune diseases have been reported in patients with WAS.</p><p>Laboratory findings include decreased number of T cells, elevated immunoglobulin A (IgA) and IgE levels, and thrombocytopenia associated with abnormally small platelets. (See  <a class="medical medical_review" href="/d/html/3953.html" rel="external">"Wiskott-Aldrich syndrome"</a>.)</p><p class="headingAnchor" id="H1045878584"><span class="h3">DiGeorge syndrome</span><span class="headingEndMark"> — </span>DiGeorge syndrome (DGS) is a disorder characterized by a constellation of signs and symptoms associated with defective development of the pharyngeal pouch system. It is caused by a heterozygous chromosomal deletion at 22q11.2 [<a href="#rid46">46</a>]. Most patients with DGS have impaired T cell production and normal humoral immunity. Other abnormalities include cleft palate, heart defects, dysmorphism, and hypoparathyroidism, depending on the size of the deletion.</p><p>A subset of patients with profound T cell deficiency presents with or develops a form of SCID referred to as atypical complete DGS. Skin findings include a papular or eczematous dermatitis that can be diffuse and erythrodermic [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/83396.html" rel="external">"DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H3010627883"><span class="h3">IPEX</span><span class="headingEndMark"> — </span>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is a rare, severe, autoimmune lymphoproliferative disorder caused by mutations in the gene for the transcription factor FOXP3 (<em>FOXP3</em>), with result in quantitative or functional deficiency of regulatory T cells [<a href="#rid47">47</a>]. Skin manifestations include diffuse erythema and eczematous or psoriasiform dermatitis. (See  <a class="medical medical_review" href="/d/html/3924.html" rel="external">"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked"</a>.)</p><p class="headingAnchor" id="H1045878591"><span class="h2">Metabolic disorders</span><span class="headingEndMark"> — </span>Acrodermatitis enteropathica is a recessively inherited partial defect in intestinal zinc absorption. It is the result of mutations in the <em>SLC39A4</em> gene, which encodes a protein that appears to be involved in zinc transportation.</p><p>Acrodermatitis enteropathica may rarely present as erythroderma in neonates [<a href="#rid3">3,5,48</a>]. Most often, it presents later in infancy with a periorificial dermatitis (<a class="graphic graphic_picture graphicRef71329" href="/d/graphic/71329.html" rel="external">picture 24</a>) or with a diffuse, scaling erythema. Other clinical symptoms include alopecia, brittle hair, diarrhea, failure to thrive, and irritability.</p><p>Cutaneous features similar to acrodermatitis enteropathica can be seen in disorders of <a class="drug drug_pediatric" data-topicid="13071" href="/d/drug information/13071.html" rel="external">biotin</a> metabolism, such as multiple carboxylase deficiency, and in other organic acidemias. Newborns with organic acidemias typically present with neurologic symptoms (eg, hypotonia, lethargy), poor feeding, and/or acidemia. The specific diagnosis is suggested by measurement of organic acids in the urine and confirmed by demonstration of deficient enzyme activity in skin fibroblasts or peripheral blood leukocytes. (See  <a class="medical medical_review" href="/d/html/5354.html" rel="external">"Zinc deficiency and supplementation in children"</a> and  <a class="medical medical_review" href="/d/html/2927.html" rel="external">"Organic acidemias: An overview and specific defects"</a>.)</p><p>Other metabolic disorders that can cause erythroderma in newborns and infants include cobalamin deficiency, maple syrup urine disease, carbamoyl phosphate synthetase deficiency, cystic fibrosis, essential fatty acid deficiency, holocarboxylase synthetase deficiency, and biotinidase deficiency. (See  <a class="medical medical_review" href="/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"</a>.)</p><p class="headingAnchor" id="H724872124"><span class="h2">Graft-versus-host disease</span><span class="headingEndMark"> — </span>Acute graft-versus-host disease (GVHD) may occur in neonates with SCID and may occasionally be the first clinical manifestation of SCID [<a href="#rid49">49,50</a>] (see <a class="local">'Severe combined immunodeficiency'</a> above). In these infants, GVHD is caused by maternal engraftment (transplacental passage of alloreactive maternal T cells) or transfusion of blood products containing viable lymphocytes. Other causes of GVHD in infants include allogenic hematopoietic stem cell transplantation and solid organ transplantation.</p><p>The skin, gastrointestinal tract, and liver are the principal involved organs in acute GVHD. Severe acute GVHD presents with generalized erythroderma with desquamation, bullae, or extensive skin detachment (<a class="graphic graphic_table graphicRef68233" href="/d/graphic/68233.html" rel="external">table 3</a>). Mucosal involvement is frequent. </p><p>A skin biopsy shows interface dermatitis with focal vacuolization of the basal layer, spongiosis, and epidermal apoptotic keratinocytes; a mild lymphocytic infiltrate is present in the papillary dermis (<a class="graphic graphic_picture graphicRef61055" href="/d/graphic/61055.html" rel="external">picture 25</a>). (See  <a class="medical medical_review" href="/d/html/3549.html" rel="external">"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease"</a>.)</p><p class="headingAnchor" id="H1045878598"><span class="h2">Drug-induced erythroderma</span><span class="headingEndMark"> — </span>Drug reactions are an infrequent cause of erythroderma in neonates and infants [<a href="#rid5">5</a>]. Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) has been rarely reported as well. If there is clinical suspicion of SJS/TEN, a skin biopsy should be taken to confirm the diagnosis. Histology typically shows subepidermal blistering, full-thickness necrosis of the epidermis, and a mild perivascular infiltrate of lymphocytes containing a variable amount of eosinophils. (See  <a class="medical medical_review" href="/d/html/2091.html" rel="external">"Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1045878605"><span class="h1">PATIENT EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>The evaluation of the erythrodermic baby involves a detailed personal and family history, physical examination, and appropriate laboratory tests [<a href="#rid48">48</a>]. In some cases, a skin biopsy may be helpful in diagnosing the underlying disease [<a href="#rid26">26</a>]. In approximately 10 percent of cases, the cause of erythroderma remains unknown. The approach to the differential diagnosis of erythroderma in neonates and infants is illustrated in the algorithms (<a class="graphic graphic_algorithm graphicRef111243 graphicRef111347" href="/d/graphic/111243.html" rel="external">algorithm 1A-B</a>).</p><p class="headingAnchor" id="H1045878612"><span class="h2">History</span><span class="headingEndMark"> — </span>A detailed history is of key importance in the evaluation of the neonate or infant with erythroderma. The clinician should obtain the parents' history of atopy (eg, asthma, allergic rhinitis, contact allergies), psoriasis, ichthyosis, and immunodeficiency. Was newborn screening performed? If so, what type? Parents' consanguinity should also be ascertained. For many of the inherited causes of erythroderma such as immunodeficiencies, ichthyoses, or metabolic diseases, family history may provide information on the inheritance pattern. A history of severe or repeated common infections may suggest a primary immunodeficiency disorder.</p><p class="headingAnchor" id="H1045878619"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>An accurate assessment of weight and rate of weight gain and growth is crucial because failure to thrive is associated with several conditions presenting with erythroderma at birth or in the first months of life (<a class="graphic graphic_algorithm graphicRef111243 graphicRef111347" href="/d/graphic/111243.html" rel="external">algorithm 1A-B</a>). Poor feeding, hypotonia, hepatomegaly, and acidosis may indicate a metabolic disorder. Clinical signs of hypocalcemia (ie, tetany, seizures) suggest DiGeorge syndrome.</p><p>Examples of cutaneous findings that may help to determine the underlying cause of erythroderma include: </p><p class="bulletIndent1"><span class="glyph">●</span>Periorificial scaling and erythema, suggesting a metabolic disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Involvement of the diaper area, suggesting psoriasis</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse, recalcitrant eczema that spares the diaper area, suggesting atopic dermatitis or immunodeficiency</p><p></p><p class="headingAnchor" id="H1045878640"><span class="h2">Laboratory and imaging tests</span><span class="headingEndMark"> — </span>Laboratory testing is based upon the clinical presentation and clinical suspicion. The initial evaluation of the erythrodermic baby may include (<a class="graphic graphic_algorithm graphicRef111243 graphicRef111347" href="/d/graphic/111243.html" rel="external">algorithm 1A-B</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complete blood count</strong> – Blood count abnormalities such as abnormal neutrophil indices (elevated or depressed absolute neutrophil count and elevated ratio of immature to total neutrophil counts), hypereosinophilia, or lymphopenia may indicate infection, atopic dermatitis, or immunodeficiency. As an example, hypereosinophilia is associated with atopic dermatitis but, in more severe cases, may be a marker of Omenn syndrome or Netherton syndrome. (See  <a class="medical medical_review" href="/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – The absence of a thymic shadow on chest radiography is a typical finding in infants with severe combined immunodeficiency (SCID). (See  <a class="medical medical_review" href="/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serum electrolytes</strong> – Because of the skin barrier impairment and insensible water loss through the erythrodermic skin, neonates are at risk of hypernatremic dehydration (weight loss ≥12 percent of birth weight and serum sodium concentration ≥150 mEq/L). (See  <a class="medical medical_review" href="/d/html/5065.html" rel="external">"Fluid and electrolyte therapy in newborns", section on 'Electrolyte disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Routine serum biochemistry</strong> – Including glucose, liver function tests, and albumin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial, fungal, or viral cultures</strong> – Nasopharyngeal umbilical, perianal, and maternal vaginal cultures should be obtained if infection is suspected. Infections with common or uncommon organisms may suggest a primary immunodeficiency.</p><p></p><p>Specific tests that may be helpful in determining the underlying cause of erythroderma are performed based upon the clinical symptoms:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>TREC/KREC testing</strong> – T cell receptor excision circles (TRECs) test or kappa-deleting recombination excision circles (KRECs) test in infants with suspected SCID or other primary immunodeficiency. (See  <a class="medical medical_review" href="/d/html/16363.html" rel="external">"Newborn screening for inborn errors of immunity"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Measurement of serum ionized calcium</strong> – Hypocalcemia may suggest hypoparathyroidism due to hypoplastic or absent parathyroids in the DiGeorge syndrome. (See  <a class="medical medical_review" href="/d/html/5060.html" rel="external">"Neonatal hypocalcemia", section on 'When to test for hypocalcemia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial blood gases</strong> – A low serum bicarbonate, low arterial pH, and increased anion gap are features of metabolic acidosis and suggest an inborn error of metabolism.</p><p></p><p class="headingAnchor" id="H1045878647"><span class="h2">Skin biopsy</span><span class="headingEndMark"> — </span>As with any case of erythroderma, the skin biopsy may be nonspecific. However, the presence of a predominant histopathologic pattern may be helpful for the diagnosis of the underlying disorder (<a class="graphic graphic_algorithm graphicRef111243 graphicRef111347" href="/d/graphic/111243.html" rel="external">algorithm 1A-B</a>) [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spongiotic pattern</strong> – The spongiotic pattern, with lymphocyte exocytosis and a mild to intense lymphocytic infiltrate of the upper dermis with or without eosinophils can be seen in atopic dermatitis, primary immunodeficiencies, and graft-versus-host disease (GVHD). The association of a spongiotic reaction pattern with keratinocyte necrosis suggests the diagnosis of immunodeficiency or GVHD. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psoriasiform pattern</strong> – The psoriasiform pattern, with epidermal hyperplasia, parakeratosis, and mild lymphocytic infiltrate can be seen in psoriasis and Netherton syndrome. Spongiform pustule and Munro abscess are typical of psoriasis, whereas little or no inflammation is present in Netherton syndrome. Immunohistochemistry with LEKTI antibody showing absence of stain is diagnostic of Netherton syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ichthyosiform pattern</strong> – The ichthyosiform pattern, with epidermal hyperplasia, compact hyperorthokeratosis, and hypergranulosis without inflammation are typically seen in ichthyoses. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acantholysis </strong>– The presence of a cleavage plane below the granular layer with acantholytic cells and a few inflammatory cells is characteristic of staphylococcal scalded skin syndrome. Full-thickness epidermal necrosis and subepidermal bullae are features of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). (See <a class="local">'Drug-induced erythroderma'</a> above.)</p><p></p><p class="headingAnchor" id="H1045878654"><span class="h2">Genetic testing</span><span class="headingEndMark"> — </span>Genetic testing is available for a growing number of primary immunodeficiencies, and neonatal screening for various forms of SCID is available in some states in the United States (US) and some other countries [<a href="#rid51">51</a>]. Information for laboratories that provide genetic test services is available at the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fgtr%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4tryNPgji1PaJ6Kbd%2Fo1hE9A6&amp;TOPIC_ID=89273" target="_blank">Genetic Testing Registry</a> website. Genetics services can be located by searching the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fclinics.acmg.net%2F&amp;token=nbsXe3i4qfUea5RCPRHtOdEP95SDL7NSm8b1jbZpdwjlW9H1hfmmq%2FTbAbE64qhV&amp;TOPIC_ID=89273" target="_blank">American College of Medical Genetics</a> website by city or state.</p><p class="headingAnchor" id="H1045878661"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H57239792"><span class="h2">Initial management</span><span class="headingEndMark"> — </span>The "red baby" with generalized erythroderma should be hospitalized for initial evaluation and treatment. Regardless of the specific etiology, the initial management involves:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring of fluids and electrolytes</strong> – Because of the increased insensible water loss, erythrodermic neonates and infants are at risk of hypernatremic dehydration (weight loss ≥12 percent of birth weight and serum sodium concentration ≥150 mEq/L). (See  <a class="medical medical_review" href="/d/html/5065.html" rel="external">"Fluid and electrolyte therapy in newborns"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring of body temperature</strong> – The transepidermal water loss is always accompanied by heat loss, resulting in hypothermia and increased metabolic rate. Neonates and infants should be placed in a warm and humid environment to minimize insensible water loss and hypothermia. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ensuring adequate nutrition</strong> – Exfoliation of the skin may result in significant protein loss and hypoalbuminemia. The increased metabolic rate is associated with an increased caloric expenditure. The caloric and protein supplementation must meet the requirements of normal growth and development and hypermetabolic state.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention and treatment of infection</strong> – Cutaneous colonization and infection with <em>S. aureus</em>, <em>Streptococcus</em>, or gram-negative bacteria are common in erythrodermic babies [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/d/html/89456.html" rel="external">"Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin care</strong> – Skin care is a critical component of the management of erythroderma. The impaired barrier function of erythrodermic skin is responsible for fluid and electrolyte imbalance, temperature instability, and susceptibility to skin colonization and infection. Regular bathing in plain water and topical, liberal application of a petrolatum-based ointment multiple times per day may be helpful in restoring the skin barrier function. </p><p></p><p class="headingAnchor" id="H57239810"><span class="h2">Treatment of underlying conditions</span><span class="headingEndMark"> — </span>After the underlying etiology of erythroderma has been determined, appropriate treatment of the underlying condition should be added to the initial management measures:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections</strong> – Treatment of staphylococcal scalded skin syndrome consists of prompt administration of intravenous penicillinase-resistant penicillin. (See <a class="local">'Staphylococcal scalded skin syndrome'</a> above.)</p><p></p><p class="bulletIndent1">In full-term infants, congenital cutaneous candidiasis tends to run a benign, self-limited course that can be managed with careful observation. Topical or systemic antifungal agents can be used if needed. (See  <a class="medical medical_review" href="/d/html/5029.html" rel="external">"Treatment of Candida infection in neonates"</a>.)</p><p></p><p class="bulletIndent1">The evaluation and management of infants with congenital syphilis is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/14428.html" rel="external">"Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome"</a>.)</p><p></p><p class="bulletIndent1">In neonates with suspected intrauterine herpes simplex virus (HSV) infection, supportive measures and appropriate antiviral therapy should be started empirically, pending laboratory investigations. (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inflammatory diseases</strong> – The treatment of erythroderma caused by atopic dermatitis includes emollients and topical corticosteroids; oral antihistamines may aid in relieving night itch. In very rare cases, infants with severe, refractory disease may require systemic corticosteroids or other immunosuppressants, such as <a class="drug drug_pediatric" data-topicid="13193" href="/d/drug information/13193.html" rel="external">cyclosporine</a> or <a class="drug drug_pediatric" data-topicid="12595" href="/d/drug information/12595.html" rel="external">methotrexate</a>, in addition to supportive measures. However, other causes of erythroderma should be carefully considered before resorting to use of systemic immunosuppression in an infant or young child. (See  <a class="medical medical_review" href="/d/html/1730.html" rel="external">"Treatment of atopic dermatitis (eczema)"</a>.) </p><p></p><p class="bulletIndent1">Treatment of erythrodermic seborrheic dermatitis includes emollients and topical corticosteroids. (See  <a class="medical medical_review" href="/d/html/16261.html" rel="external">"Cradle cap and seborrheic dermatitis in infants"</a>.)</p><p></p><p class="bulletIndent1">Infants with pityriasis rubra pilaris are usually treated with topical corticosteroids and emollients. Systemic retinoids may be necessary in severe cases [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/15283.html" rel="external">"Pityriasis rubra pilaris: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">The management of diffuse cutaneous mastocytosis involves the use of oral antihistamines and oral sodium cromoglycate [<a href="#rid27">27,53,54</a>]. Very severe cases require neonatal intensive care unit (NICU) admission for sedation because of anaphylactoid status. (See  <a class="medical medical_review" href="/d/html/4785.html" rel="external">"Cutaneous mastocytosis: Treatment, monitoring, and prognosis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ichthyoses</strong> – The management of neonates and infants with ichthyosis involves diligent skin care with regular bathing in plain water (without excessive soap) and application of emollients as often as necessary, in addition to the initial management measures described above [<a href="#rid55">55</a>]. Severe cases of lamellar ichthyosis, congenital ichthyosiform erythroderma, and Harlequin ichthyosis may require systemic retinoids [<a href="#rid56">56</a>]. (See  <a class="medical medical_review" href="/d/html/112583.html" rel="external">"Autosomal recessive congenital ichthyoses", section on 'Care of the neonate with autosomal recessive congenital ichthyoses'</a> and  <a class="medical medical_review" href="/d/html/128456.html" rel="external">"Inherited ichthyosis: Overview of management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunodeficiencies</strong> – Infants with severe combined immunodeficiency will need aggressive management in specialized centers, which involves avoidance of any potentially contagious contact, <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">immune globulin</a> replacement therapy, and prompt treatment of infection [<a href="#rid57">57</a>]. Bone marrow transplantation is the only curative therapy available for many primary immunodeficiencies. (See  <a class="medical medical_review" href="/d/html/3948.html" rel="external">"Inborn errors of immunity (primary immunodeficiencies): Overview of management"</a> and  <a class="medical medical_review" href="/d/html/115988.html" rel="external">"Hematopoietic cell transplantation for severe combined immunodeficiencies"</a>.)</p><p></p><p class="headingAnchor" id="H1045878668"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Mortality from erythroderma in neonates or infants can be significant, particularly in those with immunodeficiency. Mortality rates of 16 and 26 percent have been reported in two case series [<a href="#rid35">35,58</a>]. Sepsis, hypernatremic dehydration, and hyperpyrexia or hypothermia are the main causes of death.</p><p class="headingAnchor" id="H74772506"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and etiology</strong> – Erythroderma is an extensive and persistent erythema of the skin involving at least 90 percent of the body surface. In neonates and infants, erythroderma may be the clinical presentation of a wide range of acquired and inherited diseases, including inflammatory skin diseases, infections, ichthyoses, and congenital immunodeficiencies. (See <a class="local">'Introduction'</a> above and <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and diagnosis</strong> – The evaluation of the erythrodermic neonate or infant involves detailed personal and family history, physical examination, and appropriate laboratory tests (<a class="graphic graphic_algorithm graphicRef111243 graphicRef111347" href="/d/graphic/111243.html" rel="external">algorithm 1A-B</a>). A skin biopsy may be helpful in diagnosing the underlying disease in many patients. However, in approximately 10 percent of cases, the cause of erythroderma remains unknown. (See <a class="local">'Patient evaluation and diagnosis'</a> above and <a class="local">'Skin biopsy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial management</strong> – The "red baby" with generalized erythroderma should be hospitalized for initial evaluation and treatment. Regardless of the specific etiology, the initial management involves the monitoring of fluids and electrolytes, maintenance of the body temperature, and nutritional support. The application of petrolatum-based ointment multiple times per day may be helpful in improving the skin barrier function. (See <a class="local">'Initial management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of the underlying condition</strong> – After the etiology of erythroderma has been determined, appropriate treatment of the underlying condition should be added to the initial management measures. (See <a class="local">'Treatment of underlying conditions'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Levy ML. Erythrodermas, immunodeficiency, and metabolic disorders. In: Neonatal and Infant Dermatology, 3rd ed, Eichenfield LF, Frieden IJ, Mathes EF, Zaenglein AL (Eds), Elsevier, 2014. p.265.</li><li><a class="nounderline abstract_t">Ott H. Guidance for assessment of erythroderma in neonates and infants for the pediatric immunologist. Pediatr Allergy Immunol 2019; 30:259.</a></li><li><a class="nounderline abstract_t">Fraitag S, Bodemer C. Neonatal erythroderma. Curr Opin Pediatr 2010; 22:438.</a></li><li><a class="nounderline abstract_t">Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol 2014; 28:1418.</a></li><li><a class="nounderline abstract_t">Ott H, Hütten M, Baron JM, et al. Neonatal and infantile erythrodermas. J Dtsch Dermatol Ges 2008; 6:1070.</a></li><li><a class="nounderline abstract_t">Rostad CA, Philipsborn RP, Berkowitz FE. Evidence of staphylococcal toxic shock syndrome caused by MRSA in a mother-newborn pair. Pediatr Infect Dis J 2015; 34:450.</a></li><li><a class="nounderline abstract_t">Takahashi N, Uehara R, Nishida H, et al. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect 2009; 59:194.</a></li><li><a class="nounderline abstract_t">Takahashi N, Nishida H, Kato H, et al. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998; 351:1614.</a></li><li><a class="nounderline abstract_t">Takahashi N, Imanishi K, Uchiyama T. Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus. Microbiol Immunol 2013; 57:737.</a></li><li><a class="nounderline abstract_t">Darmstadt GL, Dinulos JG, Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 2000; 105:438.</a></li><li><a class="nounderline abstract_t">Lanternier F, Cypowyj S, Picard C, et al. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr 2013; 25:736.</a></li><li><a class="nounderline abstract_t">Rowe CR, Newberry DM, Jnah AJ. Congenital Syphilis: A Discussion of Epidemiology, Diagnosis, Management, and Nurses' Role in Early Identification and Treatment. Adv Neonatal Care 2018; 18:438.</a></li><li><a class="nounderline abstract_t">Antaya RJ, Robinson DM. Blisters and pustules in the newborn. Pediatr Ann 2010; 39:635.</a></li><li><a class="nounderline abstract_t">Zhou Q, Wang L, Chen C, et al. A case series of 130 neonates with congenital syphilis: preterm neonates had more clinical evidences of infection than term neonates. Neonatology 2012; 102:152.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.</a></li><li><a class="nounderline abstract_t">Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J 2011; 30:153.</a></li><li><a class="nounderline abstract_t">Lee R, Schwartz RA. Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review. J Am Acad Dermatol 2011; 64:152.</a></li><li><a class="nounderline abstract_t">Pérez C L, Villarroel B J, Reyes J A, et al. [Exfoliative erythroderma and infective dermatitis in an infant infected with human T-lymphotropic virus type I (HTLV I)]. Rev Chilena Infectol 2007; 24:142.</a></li><li><a class="nounderline abstract_t">Takahashi H, Takahashi I, Tsuji H, et al. Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007. J Dermatol 2009; 36:632.</a></li><li><a class="nounderline abstract_t">Kumar B, Jain R, Sandhu K, et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol 2004; 43:654.</a></li><li><a class="nounderline abstract_t">Bender AM, Levy ML. The child with recalcitrant dermatitis: when to worry? Dermatol Clin 2013; 31:223.</a></li><li><a class="nounderline abstract_t">Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009; 360:2426.</a></li><li><a class="nounderline abstract_t">Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011; 365:620.</a></li><li><a class="nounderline abstract_t">Chang SE, Choi JH, Koh JK. Congenital erythrodermic psoriasis. Br J Dermatol 1999; 140:538.</a></li><li><a class="nounderline abstract_t">Salleras M, Sanchez-Regaña M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr Dermatol 1995; 12:231.</a></li><li><a class="nounderline abstract_t">Leclerc-Mercier S, Bodemer C, Bourdon-Lanoy E, et al. Early skin biopsy is helpful for the diagnosis and management of neonatal and infantile erythrodermas. J Cutan Pathol 2010; 37:249.</a></li><li><a class="nounderline abstract_t">Koga H, Kokubo T, Akaishi M, et al. Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature. Pediatr Dermatol 2011; 28:542.</a></li><li><a class="nounderline abstract_t">Lange M, Niedoszytko M, Renke J, et al. Clinical aspects of paediatric mastocytosis: a review of 101 cases. J Eur Acad Dermatol Venereol 2013; 27:97.</a></li><li><a class="nounderline abstract_t">Lange M, Niedoszytko M, Nedoszytko B, et al. Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature. J Eur Acad Dermatol Venereol 2012; 26:1565.</a></li><li><a class="nounderline abstract_t">Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 2011; 12:259.</a></li><li><a class="nounderline abstract_t">Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 2012; 67:813.</a></li><li><a class="nounderline abstract_t">Carter MC, Clayton ST, Komarow HD, et al. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. J Allergy Clin Immunol 2015; 136:1673.</a></li><li><a class="nounderline abstract_t">Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol 2010; 63:607.</a></li><li><a class="nounderline abstract_t">Auada MP, Taube MB, Collares EF, et al. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases. Eur J Dermatol 2002; 12:263.</a></li><li><a class="nounderline abstract_t">Pruszkowski A, Bodemer C, Fraitag S, et al. Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch Dermatol 2000; 136:875.</a></li><li><a class="nounderline abstract_t">Al-Herz W, Nanda A. Skin manifestations in primary immunodeficient children. Pediatr Dermatol 2011; 28:494.</a></li><li><a class="nounderline abstract_t">Lehman H. Skin manifestations of primary immune deficiency. Clin Rev Allergy Immunol 2014; 46:112.</a></li><li><a class="nounderline abstract_t">Abrams M, Paller A. Genetic immunodeficiency diseases. Adv Dermatol 2007; 23:197.</a></li><li><a class="nounderline abstract_t">Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol 2010; 125:S182.</a></li><li><a class="nounderline abstract_t">Puck JM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci 2011; 1246:108.</a></li><li><a class="nounderline abstract_t">Freeman AF, Holland SM. The hyper-IgE syndromes. Immunol Allergy Clin North Am 2008; 28:277.</a></li><li><a class="nounderline abstract_t">Freeman AF, Holland SM. Clinical manifestations of hyper IgE syndromes. Dis Markers 2010; 29:123.</a></li><li><a class="nounderline abstract_t">Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124:1289.</a></li><li><a class="nounderline abstract_t">Venegas-Montoya E, Staines-Boone AT, Sánchez-Sánchez LM, et al. Case Report: DOCK8 Deficiency Without Hyper-IgE in a Child With a Large Deletion. Front Pediatr 2021; 9:635322.</a></li><li><a class="nounderline abstract_t">Chu EY, Freeman AF, Jing H, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 2012; 148:79.</a></li><li><a class="nounderline abstract_t">Yu S, Graf WD, Shprintzen RJ. Genomic disorders on chromosome 22. Curr Opin Pediatr 2012; 24:665.</a></li><li class="breakAll">Tan QK, Louie RJ, Sleasman JW. IPEX syndrome. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.</li><li><a class="nounderline abstract_t">Bedocs LA, O'Regan GM, Bruckner Al. Red, Scaly Babies: Neonatal Erythroderma. NeoReviews 2011; 12:e325.</a></li><li><a class="nounderline abstract_t">D'hauw A, Seyger MM, Groenen PJ, et al. Cutaneous graft-versus-host-like histology in childhood. Importance of clonality analysis in differential diagnosis. A case report. Br J Dermatol 2008; 158:1153.</a></li><li><a class="nounderline abstract_t">Katugampola RP, Morgan G, Khetan R, et al. Omenn's syndrome: lessons from a red baby. Clin Exp Dermatol 2008; 33:425.</a></li><li><a class="nounderline abstract_t">Baker MW, Grossman WJ, Laessig RH, et al. Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol 2009; 124:522.</a></li><li><a class="nounderline abstract_t">Allison DS, El-Azhary RA, Calobrisi SD, Dicken CH. Pityriasis rubra pilaris in children. J Am Acad Dermatol 2002; 47:386.</a></li><li><a class="nounderline abstract_t">Jenkinson HA, Lundgren AD, Carter MC, et al. Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review. Pediatr Dermatol 2019; 36:486.</a></li><li><a class="nounderline abstract_t">Edwards AM, Capková S. Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant. BMJ Case Rep 2011; 2011.</a></li><li><a class="nounderline abstract_t">Craiglow BG. Ichthyosis in the newborn. Semin Perinatol 2013; 37:26.</a></li><li><a class="nounderline abstract_t">Digiovanna JJ, Mauro T, Milstone LM, et al. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther 2013; 26:26.</a></li><li><a class="nounderline abstract_t">Wat M, Olicker A, Meyerson H, et al. Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome. Pediatrics 2018; 141:S408.</a></li><li><a class="nounderline abstract_t">Al-Dhalimi MA. Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 2007; 34:302.</a></li></ol></div><div id="topicVersionRevision">Topic 89273 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Levy ML. Erythrodermas, immunodeficiency, and metabolic disorders. In: Neonatal and Infant Dermatology, 3rd ed, Eichenfield LF, Frieden IJ, Mathes EF, Zaenglein AL (Eds), Elsevier, 2014. p.265.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30702169" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Guidance for assessment of erythroderma in neonates and infants for the pediatric immunologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20616730" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neonatal erythroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24841497" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Staphylococcal scalded skin syndrome: diagnosis and management in children and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19138273" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neonatal and infantile erythrodermas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25260039" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Evidence of staphylococcal toxic shock syndrome caused by MRSA in a mother-newborn pair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19615752" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9620715" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24033495" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10654973" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24240293" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Primary immunodeficiencies underlying fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30020089" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Congenital Syphilis: A Discussion of Epidemiology, Diagnosis, Management, and Nurses' Role in Early Identification and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20954610" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Blisters and pustules in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22760016" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A case series of 130 neonates with congenital syphilis: preterm neonates had more clinical evidences of infection than term neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26042815" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Sexually transmitted diseases treatment guidelines, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20811312" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A report of three cases and review of intrauterine herpes simplex virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20691499" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17453073" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : [Exfoliative erythroderma and infective dermatitis in an infant infected with human T-lymphotropic virus type I (HTLV I)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19958446" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15357744" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Epidemiology of childhood psoriasis: a study of 419 patients from northern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23557651" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The child with recalcitrant dermatitis: when to worry?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19494218" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21848462" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10233283" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Congenital erythrodermic psoriasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7501553" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Congenital erythrodermic psoriasis: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19615015" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Early skin biopsy is helpful for the diagnosis and management of neonatal and infantile erythrodermas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20678092" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22126331" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical aspects of paediatric mastocytosis: a review of 101 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22092511" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21668033" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22458675" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26044856" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20643494" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11978568" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10890989" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Neonatal and infantile erythrodermas: a retrospective study of 51 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21453308" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Skin manifestations in primary immunodeficient children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23760761" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Skin manifestations of primary immune deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18159903" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Genetic immunodeficiency diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042228" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Primary immunodeficiencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22236435" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The case for newborn screening for severe combined immunodeficiency and related disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18424333" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The hyper-IgE syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21178271" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical manifestations of hyper IgE syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20004785" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34195158" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Case Report: DOCK8 Deficiency Without Hyper-IgE in a Child With a Large Deletion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21931011" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cutaneous manifestations of DOCK8 deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23111679" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Genomic disorders on chromosome 22.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23111679" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Genomic disorders on chromosome 22.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Red, Scaly Babies: Neonatal Erythroderma</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18341659" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cutaneous graft-versus-host-like histology in childhood. Importance of clonality analysis in differential diagnosis. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18498405" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Omenn's syndrome: lessons from a red baby.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19482345" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Development of a routine newborn screening protocol for severe combined immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12196748" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pityriasis rubra pilaris in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30828864" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22693187" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23419760" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Ichthyosis in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23384018" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Systemic retinoids in the management of ichthyoses and related skin types.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29610161" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17408438" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
